48 related articles for article (PubMed ID: 28587984)
1. Abcb1a but not Abcg2 played a predominant role in limiting the brain distribution of Huperzine A in mice.
Li J; Yue M; Zhou D; Wang M; Zhang H
Food Chem Toxicol; 2017 Sep; 107(Pt A):68-73. PubMed ID: 28587984
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer resistance protein (BCRP/ABCG2) and P-glycoprotein (P-gp/ABCB1) transport afatinib and restrict its oral availability and brain accumulation.
van Hoppe S; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2017 Jun; 120():43-50. PubMed ID: 28288939
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics.
Poller B; Iusuf D; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2011 May; 39(5):729-35. PubMed ID: 21282407
[TBL] [Abstract][Full Text] [Related]
4. Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.
Tang SC; Lagas JS; Lankheet NA; Poller B; Hillebrand MJ; Rosing H; Beijnen JH; Schinkel AH
Int J Cancer; 2012 Jan; 130(1):223-33. PubMed ID: 21351087
[TBL] [Abstract][Full Text] [Related]
5. Role of the efflux transporters Abcb1 and Abcg2 in the brain distribution of olaparib in mice.
Song YK; Kim MJ; Kim MS; Lee JH; Chung SJ; Song JS; Chae YJ; Lee KR
Eur J Pharm Sci; 2022 Jun; 173():106177. PubMed ID: 35341895
[TBL] [Abstract][Full Text] [Related]
6. Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs.
Li W; Sparidans RW; Wang Y; Martins MLF; de Waart DR; van Tellingen O; Song JY; Lebre MC; van Hoppe S; Wagenaar E; Beijnen JH; Schinkel AH
Biomed Pharmacother; 2024 Jun; 175():116644. PubMed ID: 38692057
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein, CYP3A, and plasma carboxylesterase determine brain and blood disposition of the mTOR Inhibitor everolimus (Afinitor) in mice.
Tang SC; Sparidans RW; Cheung KL; Fukami T; Durmus S; Wagenaar E; Yokoi T; van Vlijmen BJ; Beijnen JH; Schinkel AH
Clin Cancer Res; 2014 Jun; 20(12):3133-45. PubMed ID: 24727322
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [
Traxl A; Mairinger S; Filip T; Sauberer M; Stanek J; Poschner S; Jäger W; Zoufal V; Novarino G; Tournier N; Bauer M; Wanek T; Langer O
Mol Pharm; 2019 Mar; 16(3):1282-1293. PubMed ID: 30694684
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) affect brain accumulation and intestinal disposition of encorafenib in mice.
Wang J; Gan C; Sparidans RW; Wagenaar E; van Hoppe S; Beijnen JH; Schinkel AH
Pharmacol Res; 2018 Mar; 129():414-423. PubMed ID: 29155017
[TBL] [Abstract][Full Text] [Related]
10. The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib.
Martínez-Chávez A; Broeders J; Lebre MC; Tibben MT; Rosing H; Beijnen JH; Schinkel AH
Eur J Pharm Sci; 2021 Apr; 159():105740. PubMed ID: 33524505
[TBL] [Abstract][Full Text] [Related]
11. Influence of efflux transporters on liver, bile and brain disposition of amitriptyline in mice.
Abaut AY; Chevanne F; Le Corre P
Int J Pharm; 2009 Aug; 378(1-2):80-5. PubMed ID: 19508886
[TBL] [Abstract][Full Text] [Related]
12. P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib.
F Martins ML; Loos NHC; Mucuk S; de Jong D; Lebre MC; Rosing H; Tibben M; Beijnen JH; Schinkel AH
Mol Pharm; 2021 Dec; 18(12):4371-4384. PubMed ID: 34730366
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein (MDR1/ABCB1) restricts brain accumulation and cytochrome P450-3A (CYP3A) limits oral availability of the novel ALK/ROS1 inhibitor lorlatinib.
Li W; Sparidans RW; Wang Y; Lebre MC; Wagenaar E; Beijnen JH; Schinkel AH
Int J Cancer; 2018 Oct; 143(8):2029-2038. PubMed ID: 29744867
[TBL] [Abstract][Full Text] [Related]
14. The role of the efflux carriers Abcg2 and Abcc2 for the hepatobiliary elimination of benzo[a]pyrene and its metabolites in mice.
Kranz J; Hessel S; Aretz J; Seidel A; Petzinger E; Geyer J; Lampen A
Chem Biol Interact; 2014 Dec; 224():36-41. PubMed ID: 25451572
[TBL] [Abstract][Full Text] [Related]
15. What next? Preferably development of drugs that are no longer transported by the ABCB1 and ABCG2 efflux transporters.
van Hoppe S; Schinkel AH
Pharmacol Res; 2017 Sep; 123():144. PubMed ID: 28578203
[No Abstract] [Full Text] [Related]
16. P-Glycoprotein (MDR1/ABCB1) Restricts Brain Accumulation of the Novel EGFR Inhibitor EAI045 and Oral Elacridar Coadministration Enhances Its Brain Accumulation and Oral Exposure.
Wang J; Susam MM; Gan C; Sparidans RW; Lebre MC; Beijnen JH; Schinkel AH
Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145346
[TBL] [Abstract][Full Text] [Related]
17. Repression of adenosine triphosphate-binding cassette transporter ABCG2 by estrogen increases intracellular glutathione in brain endothelial cells following ischemic reperfusion injury.
Shin JA; Jeong SI; Kim HW; Jang G; Ryu DR; Ahn YH; Choi JH; Choi YH; Park EM
Neurobiol Aging; 2018 Jun; 66():138-148. PubMed ID: 29574357
[TBL] [Abstract][Full Text] [Related]
18. ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral Availability.
Li W; Sparidans RW; Lebre MC; Beijnen JH; Schinkel AH
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834176
[TBL] [Abstract][Full Text] [Related]
19. An altered tissue distribution of flaxseed lignans and their metabolites in Abcg2 knockout mice.
García-Mateos D; García-Villalba R; Otero JA; Marañón JA; Espín JC; Álvarez AI; Merino G
Food Funct; 2018 Jan; 9(1):636-642. PubMed ID: 29292449
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging.
Zhang W; Xiong H; Callaghan D; Liu H; Jones A; Pei K; Fatehi D; Brunette E; Stanimirovic D
Fluids Barriers CNS; 2013 Feb; 10(1):13. PubMed ID: 23432917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
